In ovarian cancer, through gene expression analysis of tumours, significant upregulation of MRPL10 in response to HE4 overexpression has been observed, although MRPL10 overexpression was also correlated with progression free survival [26]. This evidence concerns the gene WFDC2 and ovarian cancer.